Predictors of Severe Systemic Anaphylactic Reactions in Patients with Hymenoptera Venom Allergy: Importance of Baseline Serum Tryptase-a Study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom...
Overview
Authors
Affiliations
Background: Severe anaphylaxis to honeybee or vespid stings is associated with a variety of risk factors, which are poorly defined.
Objective: Our aim was to evaluate the association of baseline serum tryptase concentrations and other variables routinely recorded during patient evaluation with the frequency of past severe anaphylaxis after a field sting.
Methods: In this observational multicenter study, we enrolled 962 patients with established bee or vespid venom allergy who had a systemic reaction after a field sting. Data were collected on tryptase concentration, age, sex, culprit insect, cardiovascular medication, and the number of preceding minor systemic reactions before the index field sting. A severe reaction was defined as anaphylactic shock, loss of consciousness, or cardiopulmonary arrest. The index sting was defined as the hitherto first, most severe systemic field-sting reaction. Relative rates were calculated with generalized additive models.
Results: Two hundred six (21.4%) patients had a severe anaphylactic reaction after a field sting. The frequency of this event increased significantly with higher tryptase concentrations (nonlinear association). Other factors significantly associated with severe reactions after a field sting were vespid venom allergy, older age, male sex, angiotensin-converting enzyme inhibitor medication, and 1 or more preceding field stings with a less severe systemic reaction.
Conclusion: In patients with honeybee or vespid venom allergy, baseline serum tryptase concentrations are associated with the risk for severe anaphylactic reactions. Preventive measures should include substitution of angiotensin-converting enzyme inhibitors.
Hymenoptera venom allergy in children.
Giovannini M, Mori F, Barni S, Saretta F, Arasi S, Castagnoli R Ital J Pediatr. 2024; 50(1):262.
PMID: 39707411 PMC: 11662473. DOI: 10.1186/s13052-024-01731-9.
Natural History and Risk Factors of Hymenoptera Venom Allergy in Dogs.
Chapman E, West E, Kosnik M, Fischer N, Favrot C, Beeler L Animals (Basel). 2024; 14(22).
PMID: 39595273 PMC: 11591281. DOI: 10.3390/ani14223220.
Risk Factors for Refractory Anaphylaxis in the Emergency Department.
Yazici R, Mutlu H, Sert E, Kokulu K, Turan O Emerg Med Int. 2024; 2024:9640278.
PMID: 39559747 PMC: 11573448. DOI: 10.1155/2024/9640278.
Lange S, Oppel E, Winkler M, Rueff F Allergol Select. 2024; 8:299-303.
PMID: 39211356 PMC: 11361272. DOI: 10.5414/ALX02524E.
Basophil Activation Test Predicts Cetuximab Anaphylaxis Severity in Alpha-Gal IgE-Positive Patients.
Kopac P, Koren A, Bidovec-Stojkovic U, Kosnik M, Dejanovic L, Mesti T Diagnostics (Basel). 2024; 14(13).
PMID: 39001293 PMC: 11240968. DOI: 10.3390/diagnostics14131403.